Breakthrough medicines now available for blood cancer, breast cancer, HIV and epilepsy, saving patients up to $194, 000
There’s new hope today for thousands of Australian patients with myeloma, breast cancer, HIV and epilepsy, with the Morrison Government expanding the listing of four key medicines on the Pharmaceutical Benefits Scheme (PBS). From 1 April, Revlimid® (lenalidomide) will be available to patients receiving maintenance treatment for newly diagnosed multiple myeloma, who have already…